Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

23.46
Delayed Data
As of May 24
 +0.81 / +3.58%
Today’s Change
14.84
Today|||52-Week Range
39.90
-24.25%
Year-to-Date

Today’s Trading

Previous close22.65
Today’s open22.96
Day’s range22.67 - 23.58
Volume257,716
Average volume (3 months)292,267
Market cap$782.5M
Dividend yield--
Data as of 4:00pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)+55.00%
Earnings growth (this year)-286.58%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.00%
P/E ratioNM
Price/Sales9.77
Price/Book2.48

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp+0.62+2.64%
SRPTSarepta Therapeutics...+0.96+5.49%
CPXXCelator Pharmaceutic...-0.71-3.98%
EGRXEagle Pharmaceutical...+1.74+3.65%
Data as of 4:00pm ET, 05/24/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$100.9M
Annual profit (last year)-$20.1M
Net profit margin-19.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers

Search for Jobs